Saturday, November 24, 2007

FDA staff urge psych warnings for two flu drugs

From the makers of the weight loss drugs Xenical/Orlistat/Alli:
"U.S. Food and Drug Administration staffers are recommending new warnings about psychiatric events observed in some patients taking Roche Holding AG's Tamiflu and GlaxoSmithKline Plc's Relenza, according to documents released on Friday."

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.